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く〉原著論文
1) Hamazaki k叫 ItomuraM., Hamazaki T., and Sawazaki S.: Effect of cooking planをoilson 
recurrent apht註ousstomatitis: a randomized空 placebo・contt叫led,do的 le-blindむ・ial.
Nutritionラ22:534圃538事2006.
OBJECTIVE: One-third of the total population seems to develop minor recurrent aphthous stomatitis 
(RAS) during their lifetime. However, well-controlled dietary intervention studies to prevent minorまAS
紅eve巧frare. The objective of the present study was to investigate whether the prevalence of哀AS
decreased with perilla oil (rich in alpha-linolenic acid). METHODS：τhi均Isubjects (8 men and 22 
women) who had minor RAS at least once a month were randomly allocated to a soybean oil group or a 
perilla oil group in a double-blind manner (experimental phase) after a run-in phase of 4 mo during which 
subjects used a reference oil, the most popular cooking oil in Japan, or a 50/50 mixture of soybean oil and 
rapeseed oil. During the experimental phase, su対ectswere asked to use soybean oil or perilla oil as the 
sole cooking oil for 8 mo. Blood samples were collected at the start and end of the experimental phase for 
fatty acid analysis of total plasma phospholipid fraction. Occurrence and needed days for healing of minor 
RAS were recorded during the two phases and compared. RESULTS: alpha-Linolenic acid concentrations 
in the plasma phospholi予idfraction increased significantly in both groups during the experimental phase 
to a similar extent. The prevalence of mi~or RAS in the experimental phase decreased significantly in 
もothgroups compared with the run-in phase to a similar extent, without intergroup differences. 
CONCLUSION: Perilla oil, which is rich in alpha-linolenic acid, was not superior to soybean oil in 
preventing minorまAS.There was a possibility that avoiding rapeseed oil might beちeneficialfor 
prevention of minor RAS. 
2) Nishizawa H., Hamazaki k吋 HamazakiT. Fujioka S., and Sawazaki S.: The relationship 
between tissue RBC n-3 fatty acids and pulse wave velocity. in vivo, 20:307・310ヲ2006.
Abstract: Consumption of n-3 fatty acids is well-known to prevent deaths from corona巧rheart disease. 
However, not many studies have investigated the e宜ectsof n-3 fatty acids on arteriosclerosis in企eeliving 
subjects.τhe pulse wave velocity between the brachia and ankles (baPWV) of 161 healthy male su同ects
was measured and the fatty acid composition of the total phospholipid fraction of their red blood cells 
(RBC) analyzed. There was a significant inverse correlation between the eicosapentaenoic acid 
concentrations in the RBC phospholipid fraction and baPWV of the subjects after adjustment for ageラ
pulse rate and diastolic pressure, or further for body mass indexラsmokingstatusラdiabetesand the ratio of 
low-density cholesterol to high-density cholesterol. Although baPWV values may not directly indicate 
arteriosclerosisラthepresent study suggests that long-term n-3 fatty acid intake is beneficial for the 
vascular system. 
3} Hamazaki K., Higashihara E., Terachi T., Takada ・ H., Matsuda T., Kawakita M., Fuse H., 
Hamazaki T., Kameyama S., Masai M叫 ChibaY., Tokunaga M., Furuya Y., Okegawa T., 
Murota T., Kawa G事 and Itomura M.: The effect of eicosapentaenoic acid on 
prostate圃specificantigen. in vivo, 20:397・401,2006. 
Abstract: The ”Study of EPA Effects on Prostate Cancer”（SEEPC) Group has been conducting a clinical 
-92 -
trial with patients who underwent radical prostatectomy. The main purpose of the SEEPC is to evaluate 
whether eicosapentaenoic acid (EPA) prevents prostate cancer (PC) recu立ence.As the surrogate marker 
of recurrenceラtheprostate-specific antigen (PSA) level was measured. However, if EPA affects the PSA 
values independently of PCラPSAmay not be a good marker of recurrence in the event of EPA treatment. 
Thusラ inthe present studyラ whetherEPA affected the PSA values was investigated using non-PC 
volunteers. Twen句fmen, of at least 50 years of age, were recruitedラ mostly丘omhospital staff The 
volunteers were randomly allocated either to the EPA group or the control. The subjects in the EPA group 
were administered EPA-ethyl ester a dose of 2400 mg/day for 12 weeksラ whereasthe controls were 
administered none. Fasting blood samples were obtained before the start of EPA administration and 4 and 
12 weeks later. The EPA concentrations in erythrocytes increased in al the subjects in the EPA group 
(174+/-96%) with no significant changes.in the control group (8.5+/-14.0%). There were no significant 
differences between the two groups in the serum PSA levels, allowing the conclusion that the PSA is an 
appropriate suπogate marker of recurrence in prostate cancer. 
4) Hamazaki K., Itomura M~， Sawazaki S., and Hamazaki T.: Fish oil reduces旬。thloss mainly 
through its anti-inflammaをoryeffects? Med. Hypotheses, 67:868-870, 2006. 
Abstrac士： Competingat several steps of arachidonic acid metabolismラn-3fatty acids reduce production 
of highly active prostaglandins and leukotrienes and exert anti-inflammatory effects. They are also 
experimentally shown to be anti-osteoporotic. Periodontitis is responsible for most tooth loss in adult 
populations. If enough n-3 fatty acids are providedラperiodontitiswith alveolar bone resorption may be 
controlledラandtooth loss may be prevented. In factラn-3fa託yacid administration lowered prostaglandin 
E(2) production, tooth movement and alveolar bone resorption in animal experiments. Aggressionラwhich
may be related with tooth loss, was also controlled with fish oiL Our cross-sectional data supported our 
hypothesis. We recruited 256 men (22-59 y of age) and 95 women (22:-66 y), counted the numbers of their 
remaining teethラandanalyzed the fatちfacid composition of the total phospholipid 企actionof RBCs.τ主e
beta-coefficient of the numbers of remaining teeth and EPA concentrations in the fraction was 0.89 (per 
1%EPAラp=O.007) after a司justmentfor 9 possible confounding factors. Long-term intervention studies 
with fish oil planned in the future should be able to test our hypothesis by just adding another very simple 
endpoint in those studies: tooth loss during the intervention period. This hypothesis may explain the 
linkage between periodontitis/tooth loss and coronary heart disease. 
5) Fujioka S吋 HamazakiK., Itomura M., Huan M吋 NishizawaH., Sawazaki S., Kitajima I叫
and Hamazaki T.: The effects of eicosapentaenoic acid-fortified food on inflammatory 
markers in healt註ysubjects - a randomizedラplacebo・controlled,double-blind study. J. 
Nutr. Sci. Vitaminol., 52:261・265,2006. 
Abstract: Epidemiological studies showed that habitual fish intakes were associated with lower blood 
inflammatory markers. In the present study the effects of a fish oil-containing food on inflammatory 
markers were investigated in healthy, mostly middle-aged subjects (59 men and 82 women) with normal 
to mildly elevated triglyceride levels. S匂dysubjects were randomly allocated to two groups in a 
double-blind manner; one group ingested an eicosapentaenoic acid (EPA)-rich fish oil-fortified drink 
(0.60 gEPA÷0.26 g docosahexaenoic acid/d. EPA group, n=68) for 12 wk. The rest of the su jects took a 
placebo (control group, n=73). Plasma levels of high sensitivity C-reactive protein (hs-C哀P)and soluble 
tumor necrosis factor-receptors 1 and 2 (sTNF-Rs 1 and 2) were measured at the start and end of 
intervention. EPA concen住ationsin the total RBC phospholipid企actionsignificantly increased by 79% in 
the EPA group at the end of the study, and they changed very litle in the control group （÷0.68%). The 
inflammatory markers did _not change in either group. It is likely that fish oil does not change hs-CRP or 
sTNF-Rs 1 or 2 in subjects without active inflammation. 
?????
6) N aoi K., Kogure S., Saito M巧 HamazakiT., and Watanabe S.: Differential effects of selective 
cyclooxygenase (COX)-1 and COX-2 inhibitiors on anorexic response and prostaglandin 
generation in various tissues induced均rzymosan. Biol. Pharm. Bull. 29:1319・1324亨2006.
ABSTRACT: We have shown that anorexic response is induced by intraperitoneal injection of zymosan 
in miceラalthoughthe role of prostaglandins in this response is relatively unknown as compared with 
lipopolysaccharide (LPS)-induced anorexic response. Indomethacin (0.5 and 2.0 mg/kg）ラanon-selective 
cyclooxygenase (COX) in己iちitor,as well as meloxicam (0.5 mg/kg), a selective COX-2 inhibitor, but not 
FR122047 (2.0 mg/kg）ラ aselective COX-1 inhiもitor,attenuated zymosan-induced anorexia. Zymosan 
injection elevated COX-2 expression in brain and liver ちutnot in smal~ intestine and colon. Meloxicam 
(0.5 mg/kg) and FR122047なeatment(2.0 mg/kg) similarly suppressed the generation of brain 
prostaglandin E2 (PGE2) and peritoneal prostacyclin (PGI2) upon司rmosaninjection. PGE2 generation in 
liver upon zymosan injection was suppressed by meloxicam (0.5 mg/kg) but not by FR122047 treatment 
(2.0 mg/kg). Our observations suggest that COX-2 plays an important role in zymosan-induced anorexiaラ
which is a similar feature in LPS-induced anorexic response. However.ラ non-selectiveinhibition by 
selective COX-1 and COX四2inhiちitorsof brain PGE2 generation upon巧mosaninjection does not 
support the role ofCOX-2 expressed in brain in zymosan-induced anorexic response. PGE2 generation in 
liver may account for peripheral role of COX-2 in zymosarトinducedanorexic response. 
く〉総説
1) 浜崎景，浜崎智仁：オメガ3脂肪酸が腫蕩移植ラットに及；ます影響について.Nutrition & 
Dietetics, 9: 10-19ラ2006.
2) 浜崎智仁ラ糸村美保：リノーノレ駿摂取の問題点一昨年9月に脂質栄養学会で行われたシン
ポジウムを受けて，脂質栄養学， 15(1),15-26, 2006. 
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